Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexia Iasonos

Showing results (61-70 of 270) with videos related to

Pageof 27
Sort By:
Gynecologic Oncology|April 25, 2021
Bevacizumab in advanced endometrial cancerMaria M Rubinstein, Shannan Dickinson, Priyanka Narayan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trialsAlexia Iasonos, Mrinal Gounder, David R Spriggs, et al.
Cancer Medicine|April 19, 2018
Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort studyAnton Oseledchyk, Renee L Gennarelli, Mario M Leitao, et al.
JAMA Oncology|March 1, 2019
Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access ProgramNoah Z Feit, Debra A Goldman, Evan Smith, et al.
The Journal of Urology|August 19, 2008
Renal cell carcinoma in young and old patients--is there a difference?R Houston Thompson, Maria A Ordonez, Alexia Iasonos, et al.
Plos One|September 22, 2017
Time to publication of oncology trials and why some trials are never publishedPaul B Chapman, Nathan J Liu, Qin Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Basket Trials in Oncology: A Trade-Off Between Complexity and EfficiencyKristen M Cunanan, Mithat Gonen, Ronglai Shen, et al.
The Lancet. Oncology|November 4, 2006
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based studyEthan Basch, Alexia Iasonos, Tiffani McDonough, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2014
Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancerRachel N Grisham, Gopa Iyer, Evis Sala, et al.
Gynecologic Oncology|August 23, 2011
Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancersDavid M Hyman, Qin Zhou, Angela G Arnold, et al.
Pageof 27

Showing results (61-70 of 270) with videos related to

Sort By:
Pageof 27
Gynecologic Oncology|April 25, 2021
Bevacizumab in advanced endometrial cancerMaria M Rubinstein, Shannan Dickinson, Priyanka Narayan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
The impact of non-drug-related toxicities on the estimation of the maximum tolerated dose in phase I trialsAlexia Iasonos, Mrinal Gounder, David R Spriggs, et al.
Cancer Medicine|April 19, 2018
Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort studyAnton Oseledchyk, Renee L Gennarelli, Mario M Leitao, et al.
JAMA Oncology|March 1, 2019
Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access ProgramNoah Z Feit, Debra A Goldman, Evan Smith, et al.
The Journal of Urology|August 19, 2008
Renal cell carcinoma in young and old patients--is there a difference?R Houston Thompson, Maria A Ordonez, Alexia Iasonos, et al.
Plos One|September 22, 2017
Time to publication of oncology trials and why some trials are never publishedPaul B Chapman, Nathan J Liu, Qin Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Basket Trials in Oncology: A Trade-Off Between Complexity and EfficiencyKristen M Cunanan, Mithat Gonen, Ronglai Shen, et al.
The Lancet. Oncology|November 4, 2006
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based studyEthan Basch, Alexia Iasonos, Tiffani McDonough, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2014
Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancerRachel N Grisham, Gopa Iyer, Evis Sala, et al.
Gynecologic Oncology|August 23, 2011
Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancersDavid M Hyman, Qin Zhou, Angela G Arnold, et al.
Pageof 27